Antifection

Sannamycin F is an aminoglycoside antibiotic that primarily targets bacterial protein synthesis. It exhibits weak antibacterial activity against both Gram-positive and Gram-negative bacteria. This compound is suitable for studies focusing on antibiotic resistance mechanisms and the development of new antimicrobial agents.

Platenomycin C3 is a macrolide antibiotic that targets Gram-positive bacteria through inhibition of bacterial fatty acid synthesis. Exhibiting potent antimicrobial activity, it is particularly effective against various strains of resistant pathogens. This compound serves as a valuable research tool for studies focused on antibiotic resistance and bacterial metabolism.

1-Hydroxysulfurmycin A is an anthracycline antibiotic that exerts its primary activity through the intercalation of DNA, disrupting replication and transcription processes. This compound demonstrates significant antitumor properties and exhibits activity against Gram-positive bacteria. It is primarily utilized in cancer research and studies focused on bacterial resistance mechanisms.

Ticarcillin monosodium is a semisynthetic, extended-spectrum carboxypenicillin with notable antibacterial activity targeting gram-positive cocci, such as streptococci and staphylococci, as well as a broad range of gram-negative organisms, including Pseudomonas aeruginosa. This compound is utilized in research related to lower respiratory tract infections, skin and skin structure infections, urinary tract infections, and intraabdominal infections. Its diverse spectrum of activity makes it a valuable tool for studying various infectious diseases.

Pyrrolosporin A is an antibiotic that exhibits activity against Gram-negative bacteria. It demonstrates weak bactericidal properties, making it of interest in studies focused on antibiotic resistance and the mechanisms of bacterial infection. This compound can serve as a valuable tool in research aimed at developing new antimicrobial therapies.

Mureidomycin A is an antibiotic that exhibits potent activity against Pseudomonas aeruginosa. This compound inhibits bacterial protein synthesis, making it a valuable tool in studying bacterial resistance and developing new therapeutic strategies. Its specific targeting of pathogenic bacteria supports research in infectious disease and antibiotic development.

Neutramycin is a neutral macrolide antibiotic that targets bacterial protein synthesis by binding to the 50S ribosomal subunit. It exhibits broad-spectrum antimicrobial activity, making it effective against a variety of Gram-positive and Gram-negative bacteria. This compound is utilized in research applications focused on antibiotic resistance, mechanisms of action in microbial physiology, and the development of new therapeutic strategies.

Promothiocin B is an antibiotic that primarily targets bacterial cell wall synthesis. It exhibits potent antibacterial activity with a minimum induction concentration of 0.1 μg/mL for the tipA promoter. This compound is valuable for research applications involving the study of antibiotic mechanisms and resistance, as well as in the development of novel therapeutic strategies against bacterial infections.

Griseoviridin is an Estopeptide antibiotic that primarily targets bacterial cell wall synthesis. This compound exhibits potent activity against Gram-positive bacteria and demonstrates selective effects on certain Gram-negative bacteria. It is useful in research applications involving antimicrobial susceptibility testing and the study of antibiotic resistance mechanisms.

Pyrisulfoxin B is an antibiotic derived from the bacterium Streptomyces callfornicus BS-75. It exhibits significant antibacterial activity, making it suitable for research focused on antimicrobial agents and their mechanisms of action. Pyrisulfoxin B can be utilized in studies investigating antibiotic resistance and developing novel therapeutic strategies.

Tetromycin C5 is a broad-spectrum antibiotic targeting gram-positive bacteria, including strains that exhibit drug resistance. It demonstrates significant antibacterial activity, making it a valuable tool for research in infectious disease and antibiotic resistance studies. This compound is ideal for exploring mechanisms of antimicrobial action and developing novel therapeutic strategies.

Collinone is a recombinant angular polyketide antibiotic that exhibits antibacterial activity primarily against gram-positive bacteria. In addition to its antimicrobial properties, Collinone demonstrates cytotoxic effects, making it a valuable compound for research in microbial resistance and bioactivity studies. Its unique structure and mechanism of action provide insights into antibiotic development and potential therapeutic applications.

Gepotidacin hydrochloride is a novel antibacterial agent that inhibits bacterial type II topoisomerases. By interfering with DNA replication and repair processes, it exhibits potent activity against a range of Gram-negative and Gram-positive bacteria. This compound is primarily utilized in research focused on bacterial infections and the development of new antibacterial therapies.

Polymyxin T1 is an antibiotic derived from Bacillus polymyxa E-12, primarily targeting Gram-negative bacteria. It exhibits bactericidal activity by disrupting the bacterial cell membrane, leading to cell lysis. Due to its specific action, Polymyxin T1 is valuable for research in studying bacterial resistance and exploring new antimicrobial strategies.

Seldomycin factor 3 is an aminoglycoside antibiotic that exhibits a broad spectrum of antimicrobial activity. It is primarily used in research applications to investigate mechanisms of bacterial resistance and to study antibiotic efficacy against various microbial strains. This compound serves as a valuable tool in the development of new therapeutic strategies to combat infectious diseases.

Fluopsin F is an antitumor antibiotic that demonstrates significant antibacterial properties against both Gram-positive and Gram-negative bacteria. Its unique composition containing metallic iron contributes to its efficacy in targeting and inhibiting tumor growth. Fluopsin F is suitable for research applications focused on cancer treatment and antibiotic resistance studies.

Hormaomycin is a potent and selective macrocyclic antibiotic agent that targets bacterial cell membranes. It exhibits broad-spectrum antibiotic activity against various Gram-positive bacteria. This compound is valuable for research applications focused on bacterial resistance mechanisms and the development of novel antimicrobial therapies.

3-Hydroxyrifamycin S is an Ansamycin antibiotic that targets bacterial ribosomes to inhibit protein synthesis. This compound exhibits significant activity against Gram-positive bacteria while demonstrating weaker efficacy against Gram-negative bacteria. It is primarily utilized in research focused on antibiotic resistance and the mechanisms of bacterial infection.

Gentamicin B is an aminoglycoside antibiotic derived from Micromonospora echinospora. It exhibits potent antibacterial activity against a broad spectrum of Gram-negative bacteria. This compound is primarily utilized in research focusing on its potential for inducing ataxia and evaluating renal toxicity.

Amythiamicin D is a thiopeptide antibiotic that primarily targets Gram-positive bacteria, effectively inhibiting their growth. It demonstrates significant antibacterial activity and is utilized in research applications focusing on bacterial resistance mechanisms and the exploration of novel antimicrobial agents. This compound serves as a valuable tool for investigating the pharmacological properties and therapeutic potential of thiopeptide antibiotics.

Saroaspidin C is an antibiotic compound derived from Sarothra japonica. It exhibits potent antibacterial activity, making it a valuable tool for research in microbiology and infectious disease studies. This compound can be utilized to investigate mechanisms of action against bacterial pathogens and to explore new therapeutic strategies for treating infections.

Kapurimycin A1 is an antitumor antibiotic derived from Streptomyces species. It displays potent inhibitory activity against Gram-positive bacteria and exhibits cytotoxic effects on cultured mammalian cells. Additionally, Kapurimycin A1 has demonstrated strong antitumor efficacy against the mouse leukemia P388 cell line, making it a valuable tool for cancer research studies.

Napsamycin D is an antibiotic that targets bacterial cell growth. It exhibits strong antibacterial activity specifically against Pseudomonas aeruginosa and other Pseudomonas species, while displaying limited efficacy against other Gram-positive and Gram-negative bacteria. This compound is useful in research settings focused on bacterial infections and antibiotic resistance studies.

Macquarimicin B is an antibiotic that primarily targets bacterial RNA synthesis. It exhibits potent antibacterial activity against a range of Gram-positive bacteria, making it valuable in the study of antibiotic resistance and bacterial pathogenesis. This compound is applicable in research focused on the mechanisms of action of antibiotics and the development of novel therapeutic agents for bacterial infections.

Atrovenetin is an antibiotic derived from Penicillium species that primarily targets bacterial infections. It demonstrates inhibitory activity against Bacillus subtilis and Staphylococcus aureus, making it relevant for studies on bacterial resistance and antibiotic efficacy. Additionally, Atrovenetin exhibits potent antioxidant properties, contributing to its potential use in research focused on oxidative stress and related biological pathways.

Polymyxin A2 is a heteropeptide antibiotic that targets the outer membrane of Gram-negative bacteria, disrupting membrane integrity and leading to cell death. It exhibits stronger antibacterial activity against Gram-negative strains compared to Gram-positive counterparts. Polymyxin A2 is primarily used in microbiological research to study antibiotic resistance mechanisms and to evaluate the efficacy of new antimicrobial agents.

Baumycin B1 is an antitumor antibiotic that functions by inhibiting DNA synthesis and disrupting cellular replication. This compound exhibits significant cytotoxicity against a variety of cancer cell lines, making it a valuable tool for cancer research. Its mechanism of action offers potential insights into therapeutic strategies for tumor treatment and provides a basis for further investigation into its biological effects.

Aspergillic acid is an antibiotic derived from Aspergillus flavus, primarily targeting bacterial pathogens. It exhibits a broad spectrum of antibacterial activity, making it a valuable reagent for microbiological studies. Aspergillic acid is often utilized in research applications focused on antibiotic resistance and the development of new antimicrobial agents.

Propionylmaridomycin is a macrolide antibiotic that exhibits potent antibacterial activity. Following oral administration, it is rapidly absorbed and distributed to various tissues, demonstrating significantly higher concentration levels in the liver, kidneys, and lungs compared to plasma. Its superior antibacterial efficacy is particularly noted in pulmonary tissue, and it is predominantly excreted through feces. In metabolic studies on rats, Propionylmaridomycin is extensively metabolized, with 4''-depropionyl-9-propionylmaridomycin identified as the principal metabolite. This compound is valuable for research into antibiotic effectiveness and microbial resistance mechanisms.

Ericamycin is a potent antibiotic that targets Gram-positive bacteria, demonstrating significant antibacterial activity. It effectively inhibits the growth of Staphylococcus aureus with a minimal inhibitory concentration (MIC) range of 0.004 to 0.016 µg/mL. This compound is valuable for research focused on antibiotic resistance and the study of bacterial infections.

7β,8β-Epoxyroridin H is an antibiotic targeting a wide range of bacterial strains. It exhibits significant activity against both Gram-positive and Gram-negative bacteria, making it a valuable tool in antimicrobial research. This compound is suitable for studies investigating bacterial resistance mechanisms and the development of novel antibacterial therapies.

Fluvirucin B5 is an antibiotic that specifically targets the influenza A virus. This compound exhibits potent antiviral activity, making it valuable for research into influenza infections and the mechanisms of antiviral resistance. It is useful in studies aimed at understanding viral pathogenesis and developing therapeutic strategies against influenza A.

Parvodicin B2 is a glycopeptide antibiotic that targets bacterial cell wall synthesis. This compound exhibits potent inhibitory activity against Staphylococcus aureus, Staphylococcus furfur, Staphylococcus hemolyticus, and Enterococcus faecalis. Parvodicin B2 is valuable for research applications focusing on antibiotic resistance and bacterial infections.

Epithienamycin C is a carbapenem antibiotic that exhibits strong activity against both Gram-positive and Gram-negative bacteria. This compound targets bacterial cell wall synthesis, making it effective in various microbiological research applications. Its broad-spectrum efficacy positions it as a valuable reagent for studies exploring antibiotic mechanisms and resistance.

Griseorhodin G is a quinone antibiotic known for its ability to inhibit bacterial growth. This compound exhibits notable antitumor activity, making it relevant for cancer research applications. Its unique mechanism of action may offer insights into developing new therapeutic strategies against resistant microbial strains and cancer cells.

Miyakamide B1 is an antitumor antibiotic that exerts its effects through the inhibition of cellular growth. It demonstrates notable cytotoxicity against P388 leukemia cells, exhibiting an IC50 value of 8.8 μg/mL. Additionally, Miyakamide B1 displays insecticidal properties, contributing to its potential applications in both cancer research and agricultural pest management. This compound may serve as a valuable tool for studies focused on antitumor mechanisms and insecticidal activity.

Butylcycloheptylprodigiosin is a red-pigmented antibiotic derived from bacterial secondary metabolism, particularly from strains of Streptomyces. This compound displays significant cytotoxicity against cancer cell lines, including MCF-7, and also affects human dermal fibroblasts (HDF). Its antibacterial properties make it a valuable tool for research into novel antimicrobial therapies and cancer treatment strategies.

Cefmatilen is an orally-active cephalosporin antibiotic that targets bacterial cell wall synthesis. It demonstrates significant antimicrobial activity against a range of Gram-positive and Gram-negative bacteria, including Streptococcus pyogenes and Neisseria gonorrhoeae. This compound is useful for research applications focused on antibiotic resistance and the mechanisms of bacterial pathogenesis.

Helvecardin B is a glycopeptide antibiotic that exerts its effects by disrupting bacterial cell wall synthesis. It demonstrates potent activity against both aerobic and anaerobic Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Helvecardin B is useful in microbiological studies and antibiotic resistance research, contributing to the understanding of mechanisms underlying bacterial infections and treatment strategies.

Saframycin C is an analog of the antibiotic soramycin, characterized as the 0-methyl derivative of racemomycin B. This compound exhibits significant antibacterial activity, making it a valuable tool for microbiological research. Its unique structure and mode of action provide insights into antibiotic mechanisms and potential therapeutic applications in combating resistant bacterial strains.

Pyrrolomycin C is an antibiotic that targets bacterial ribosomes, inhibiting protein synthesis and thereby exerting antimicrobial activity. Isolated from Actinosporangium species, it demonstrates potent effects against a range of Gram-positive bacteria. Pyrrolomycin C is valuable for research applications in microbiology and antibiotic development.

Micacocidin B is an antibiotic derived from Pseudomonas sp. No. 57, with potent activity against Mycoplasma species. This compound serves as a valuable research tool for studying bacterial infections and developing antimicrobial strategies. Its efficacy against specific pathogens makes it a critical reagent for microbiological investigations.

Napyradiomycin B3 is an antibiotic with a primary mechanism of action against Gram-positive bacteria and mycobacterial species. It exhibits potent antibacterial activity, making it a valuable tool for research in infectious diseases and the development of new antimicrobial agents. Its unique properties support investigations into bacterial resistance and the efficacy of novel therapeutic strategies.

Enamidonin is a lipopeptide antibiotic that primarily targets epidermal growth factor (EGF) signaling pathways. It demonstrates a significant ability to inhibit EGF-dependent [3H] thymidine incorporation in Balb/MK cells, with an IC50 of 10 µg/mL. Additionally, Enamidonin has the capacity to restore the altered morphology of SRCTS-NRK cells to a normal flat configuration, with an effective dose (ED50) of 10 µg/mL. This compound is valuable for research applications exploring cell signaling and morphology in the context of antibiotic activity.

Pyloricidin D is an antibiotic targeting Helicobacter pylori, derived from Bacillus sp. HC-70. It exhibits potent antimicrobial activity against this pathogen, making it valuable for research focused on gastrointestinal infections and antibiotic development. Its mechanism of action contributes to the understanding of bacterial resistance and the viability of alternative therapeutic strategies.

Menoxymycin A is an antitumor antibiotic that exerts its effects primarily through cytotoxic activity. It demonstrates potent inhibition of KB and N18-RE-105 cancer cell lines, with IC50 values of 0.86 μM and 0.14 μM, respectively. This compound serves as a valuable tool for research into cancer therapeutics and mechanistic studies of antibiotic action against tumor cells.

Streptothricin F is a bactericidal antibiotic that primarily targets the 30S subunit of the 70S ribosome, disrupting protein synthesis in susceptible bacteria. It demonstrates rapid bactericidal activity against highly drug-resistant, carbapenem-resistant Enterobacterales (CRE), with MIC50 and MIC90 values of 2 and 4 μM, respectively, and is also effective against Acinetobacter baumannii. This compound is valuable for research applications focused on antibiotic resistance and the development of new antimicrobial therapies.

11-Deoxy-13-deoxodaunorubicin is an anthracycline antibiotic that primarily targets bacterial and tumor cells. This compound exhibits significant antibacterial activity against both Gram-positive and Gram-negative bacteria, as well as antitumor effects. It is commonly utilized in research applications related to oncology and microbiology.

Halomicin A is an ansamycin antibiotic known for its broad-spectrum antibacterial properties. It exhibits activity against both Gram-positive and Gram-negative bacteria, making it a valuable reagent for researching antibiotic resistance and microbial inhibition. This compound is essential for investigations into bacterial pathogenesis and the development of new antimicrobial therapies.

(-)-cis-Myrtanol is a terpenoid compound with notable antibacterial properties, primarily targeting harmful gut bacteria such as Bifidobacterium bifidum. This compound, derived from Artemisia dracunculus, demonstrates effective antimicrobial activity, making it a valuable reagent for research in gastrointestinal health and antibiotic development. Its potential applications in microbiological studies further highlight its significance in understanding gut microbiota interactions and therapeutic strategies.